Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Aggression × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 297 Ovarian Neoplasms 160 Lung Neoplasms 152 Breast Neoplasms 101 Fallopian Tube Neoplasms 78 Neoplasms 72 Carcinoma, Ovarian Epithelial 64 Small Cell Lung Carcinoma 45 Squamous Cell Carcinoma of Head and Neck 44 Triple Negative Breast Neoplasms 35 Neoplasm Metastasis 35 Head and Neck Neoplasms 34 Adenocarcinoma of Lung 34 Central Nervous System Neoplasms 29 Brain Neoplasms 26 Neuroblastoma 25 Carcinoma 24 Recurrence 23 Endometrial Neoplasms 23 Urinary Bladder Neoplasms 22 Lymphoma, Large B-Cell, Diffuse 22 Lymphoma 22 Parkinson Disease 4, Autosomal Dominant Lewy Body 21 Esophageal Neoplasms 21 Astrocytoma 20 Testicular Neoplasms 19 Adenocarcinoma, Bronchiolo-Alveolar 19 Melanoma 18 Stomach Neoplasms 17 Glioma 17

Interventions

vandetanib 1 selinexor 1 pegfilgrastim 1 midostaurin 1 Topotecan 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡